| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.0083 | 0.8 |